322 related articles for article (PubMed ID: 25483665)
1. Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.
NoeDominguez-Romero A; Zamora-Alvarado R; Servín-Blanco R; Pérez-Hernández EG; Castrillon-Rivera LE; Munguia ME; Acero G; Govezensky T; Gevorkian G; Manoutcharian K
Hum Vaccin Immunother; 2014; 10(11):3201-13. PubMed ID: 25483665
[TBL] [Abstract][Full Text] [Related]
2. Generation of multiepitope cancer vaccines based on large combinatorial libraries of survivin-derived mutant epitopes.
Domínguez-Romero AN; Martínez-Cortés F; Munguía ME; Odales J; Gevorkian G; Manoutcharian K
Immunology; 2020 Oct; 161(2):123-138. PubMed ID: 32619293
[TBL] [Abstract][Full Text] [Related]
3. Variable epitope libraries: new vaccine immunogens capable of inducing broad human immunodeficiency virus type 1-neutralizing antibody response.
Charles-Niño C; Pedroza-Roldan C; Viveros M; Gevorkian G; Manoutcharian K
Vaccine; 2011 Jul; 29(32):5313-21. PubMed ID: 21600948
[TBL] [Abstract][Full Text] [Related]
4. Variable epitope library-based vaccines: shooting moving targets.
Pedroza-Roldan C; Charles-Niño C; Saavedra R; Govezensky T; Vaca L; Avaniss-Aghajani E; Gevorkian G; Manoutcharian K
Mol Immunol; 2009 Dec; 47(2-3):270-82. PubMed ID: 19853920
[TBL] [Abstract][Full Text] [Related]
5. Generation of cancer vaccine immunogens derived from major histocompatibility complex (MHC) class I molecules using variable epitope libraries.
Servín-Blanco R; Chávaro-Ortiz RM; Zamora-Alvarado R; Martínez-Cortes F; Gevorkian G; Manoutcharian K
Immunol Lett; 2018 Dec; 204():47-54. PubMed ID: 30339819
[TBL] [Abstract][Full Text] [Related]
6. Generation of cancer vaccine immunogens derived from Oncofetal antigen (OFA/iLRP) using variable epitope libraries tested in an aggressive breast cancer model.
Martínez-Cortés F; Servín-Blanco R; Domínguez-Romero AN; Munguía ME; Guzman Valle J; Odales J; Gevorkian G; Manoutcharian K
Mol Immunol; 2021 Nov; 139():65-75. PubMed ID: 34454186
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine.
Ohtake J; Ohkuri T; Togashi Y; Kitamura H; Okuno K; Nishimura T
Immunol Lett; 2014 Sep; 161(1):20-30. PubMed ID: 24794408
[TBL] [Abstract][Full Text] [Related]
8. Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses.
Xie Y; Chen Y; Ahmed KA; Li W; Ahmed S; Sami A; Chibbar R; Tang X; Tao M; Xu J; Xiang J
Cancer Gene Ther; 2013 Oct; 20(10):590-8. PubMed ID: 24052129
[TBL] [Abstract][Full Text] [Related]
9. Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+ T Help in BALB/c Mice.
Ghaffari-Nazari H; Tavakkol-Afshari J; Jaafari MR; Tahaghoghi-Hajghorbani S; Masoumi E; Jalali SA
PLoS One; 2015; 10(11):e0142563. PubMed ID: 26556756
[TBL] [Abstract][Full Text] [Related]
10. PolyI:C and mouse survivin artificially embedding human 2B peptide induce a CD4+ T cell response to autologous survivin in HLA-A*2402 transgenic mice.
Kasamatsu J; Takahashi S; Azuma M; Matsumoto M; Morii-Sakai A; Imamura M; Teshima T; Takahashi A; Hirohashi Y; Torigoe T; Sato N; Seya T
Immunobiology; 2015 Jan; 220(1):74-82. PubMed ID: 25257859
[TBL] [Abstract][Full Text] [Related]
11. Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer.
Singh R; Paterson Y
Cancer Res; 2006 Aug; 66(15):7748-57. PubMed ID: 16885378
[TBL] [Abstract][Full Text] [Related]
12. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
Rice J; Buchan S; Stevenson FK
J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
[TBL] [Abstract][Full Text] [Related]
13. Prediction and identification of novel IBV S1 protein derived CTL epitopes in chicken.
Tan L; Liao Y; Fan J; Zhang Y; Mao X; Sun Y; Song C; Qiu X; Meng C; Ding C
Vaccine; 2016 Jan; 34(3):380-6. PubMed ID: 26620841
[TBL] [Abstract][Full Text] [Related]
14. Measles Vaccines Designed for Enhanced CD8
Busch E; Kubon KD; Mayer JKM; Pidelaserra-Martí G; Albert J; Hoyler B; Heidbuechel JPW; Stephenson KB; Lichty BD; Osen W; Eichmüller SB; Jäger D; Ungerechts G; Engeland CE
Viruses; 2020 Feb; 12(2):. PubMed ID: 32098134
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma.
Ciesielski MJ; Kozbor D; Castanaro CA; Barone TA; Fenstermaker RA
Cancer Immunol Immunother; 2008 Dec; 57(12):1827-35. PubMed ID: 18438666
[TBL] [Abstract][Full Text] [Related]
16. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI
Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579
[TBL] [Abstract][Full Text] [Related]
17. Antitumor efficacy of MUC1-derived variable epitope library treatments in a mouse model of breast cancer.
Odales J; Servín-Blanco R; Martínez-Cortés F; Guzman Valle J; Domínguez-Romero AN; Gevorkian G; Manoutcharian K
Vaccine; 2022 Aug; 40(33):4796-4805. PubMed ID: 35788294
[TBL] [Abstract][Full Text] [Related]
18. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium.
Tanaka K; Enomoto N; Uehara M; Furuhashi K; Sakurai S; Yasui H; Karayama M; Hozumi H; Suzuki Y; Fujisawa T; Inui N; Nakamura Y; Nagata T; Suda T
Microbiol Immunol; 2020 Oct; 64(10):666-678. PubMed ID: 32786043
[TBL] [Abstract][Full Text] [Related]
20. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
